Daily non-political popular news in brief.
As dialysis becomes a target of cost control, doctor-patient relationship is key
06-13-2007 · EurekAlert!As medical, economic, and policy trends converge to alter the way dialysis care is organized and financed, protecting the unique relationship between dialysis patients and the kidney specialists who direct their care is a top priority, according to a special feature in the July Journal of the American Society of Nephrology.
Read more »
Keywords: dialysis, becomes, target, cost, control, doctor-patient, relationship, key, dialysi, become, doctor, patient
« Previous | Next »
Similar news on "As dialysis becomes a target of cost control, doctor-patient relationship is key":
- Cost control measures limit patient and physician choice in psychotropic medications
03-01-2007 · EurekAlert!
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.
Similar news · Read more »
- Does this child have appendicitis? Watch out for key signs
08-02-2007 · EurekAlert!
A 5-year-old with abdominal pain, nausea and fever may have appendicitis or any of a number of other problems. But how does the child's doctor decide whether to schedule an emergency appendectomy to surgically remove a presumably inflamed appendix -- a procedure that carries its own risks like any surgery -- or wait and observe what could be a ticking time bomb that could rupture and kill the patient in a matter of hours?
Similar news · Read more »
- Targeted HIV testing more effective than CDC mass testing proposal
06-11-2007 · EurekAlert!
A targeted campaign of testing and counseling aimed at those who are at high risk for HIV would be more effective than the mass patient screening proposed by the Centers for Disease Control and Prevention, according to an analysis by David Holtgrave, Ph.D., an expert on HIV prevention at the Johns Hopkins Bloomberg School of Public Health. Holtgrave's study is the first to examine the cost-effectiveness of the CDC's testing plan.
Similar news · Read more »
- Penn researchers discover novel pathway for increasing 'good' cholesterol
08-08-2007 · EurekAlert!
Researchers have discovered that a group of liver enzymes may be the key to raising levels of good cholesterol. The pathway by which these proteins are able to achieve an increase in HDL cholesterol involves another enzyme that normally degrades HDL-C. The newly recognized relationship between these enzymes and cholesterol represents another target for ultimately controlling good cholesterol.
Similar news · Read more »
- Role of a key enzyme in reducing heart disease identified
10-24-2007 · EurekAlert!
Virginia Commonwealth University researchers have identified the role of a key enzyme called CEH in reducing heart disease, paving the way for new target therapies to reduce plaques in the arteries and perhaps in the future, help predict a patient's susceptibility to heart disease.
Similar news · Read more »
- Hepatitis B patients' understanding of infection and treatment deficient
05-24-2007 · EurekAlert!
Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA survey that suggests improved patient involvement in disease management decisions could be the key to fixing this problem.
Similar news · Read more »
- Medication costs infrequently addressed when newly prescribed, UCLA study finds
11-08-2006 · EurekAlert!
A new UCLA study has found that physicians discuss cost and aspects of obtaining newly prescribed medications only about one-third of the time during patient/doctor interactions.But questions about pricing and prescription drug insurance coverage are critical -- the high costs of drugs, including out-of-pocket payouts such as co-payments, are linked to patient non-adherence in maintaining their dosage schedules
Similar news · Read more »
- Early-stage immune system control of HIV may depend on inherited factors
11-03-2006 · EurekAlert!
How well an individual's immune system controls HIV during the earliest phases of infection appears to depend on both the specific versions of key immune-system molecules called HLA Class I that have been inherited, as well as on the fragments of viral protein those molecules display to the T lymphocytes that usually destroy infected cells.
Similar news · Read more »
- New simulator is next step on the road to developing quantum computers
11-26-2006 · EurekAlert!
Scientists have proven theoretically a novel way to build a simulator that can recreate the way atoms and particles behave in a quantum system, says research published today. The proposed simulator is unique because it could let researchers control how individual particles move and interact with each other. This ability to control individual parts of a quantum system is key to the development of powerful quantum computers in the future.
Similar news · Read more »
- Detailed 3-D image catches a key regulator of neural stem cell differentiation in action
12-07-2006 · EurekAlert!
Researchers at the Salk Institute for Biological Studies in collaboration with scientists at the University of California, San Diego took a high resolution "action shot" of a protein switch that plays a crucial role in the development of the nervous system. Their findings, published in the December 8 issue of the journal Molecular Cell, provide a template for the design of small molecule inhibitors to control that switch, a protein called Scp1, at will.
Similar news · Read more »
